J. Goldman & CO LP Sarepta Therapeutics, Inc. Put Options Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $2.49 Million - $3.14 Million	20,000 New	20,000 $2.5 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $3.83 Million - $6.78 Million	-50,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $3.64 Million - $7.85 Million	50,000 New	50,000 $3.77 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $3.46 Million - $4.85 Million	-30,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $2.15 Million - $4.61 Million	30,000 New	30,000 $3.97 Million

508

88.9M

1.39M

1.13M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.83B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.